EFFECTS OF INTRANASAL GLUCOCORTICOIDS ON ENDOGENOUS GLUCOCORTICOID PERIPHERAL AND CENTRAL FUNCTION

Citation
U. Knutsson et al., EFFECTS OF INTRANASAL GLUCOCORTICOIDS ON ENDOGENOUS GLUCOCORTICOID PERIPHERAL AND CENTRAL FUNCTION, Journal of Endocrinology, 144(2), 1995, pp. 301-310
Citations number
36
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
00220795
Volume
144
Issue
2
Year of publication
1995
Pages
301 - 310
Database
ISI
SICI code
0022-0795(1995)144:2<301:EOIGOE>2.0.ZU;2-P
Abstract
Glucocorticoids are among the most potent antiinflammatory agents that can be used in the treatment of rhinitis. Their mechanisms of action are multiple and complex and a number of reports describe significant systemic effects of locally administered glucocorticoids. In order to evaluate the short-term systemic effects of intranasally administered glucocorticoids, 14 normal healthy subjects were treated with two dose s of either budesonide (BUD) or fluticasone propionate (FP) for 2 week s. Before treatment, at regular intervals during the treatment, 1 week and finally 6 weeks after termination of treatment, the effects on gl ucocorticoid receptor (GR) and methallothionein (MTIIa) mRNA expressio n levels were examined in peripheral lymphocytes using a solution hybr idization assay. Serum cortisol, osteocalcin and urinary cortisol leve ls were also determined. An insulin tolerance test (ITT) was performed at the end of the second week of treatment and at the end of the 6-we ek washout period with no statistically significant change in cortisol response. In peripheral lymphocytes, GR mRNA levels were significantl y down-regulated. MTIIa mRNA levels increased significantly. Serum ost eocalcin decreased significantly during treatment with both BUD and FP . Serum cortisol decreased after 1 week of treatment whereas urinary c ortisol was not affected until the second week of treatment. In conclu sion, intranasal glucocorticoids at clinically recommended doses have not only significant systemic effects on adrenal function, but also ha ve an effect on specific gene expression in peripheral lymphocytes. Th ese effects are receptor-dependent, reversible, and according to serum and urinary cortisol levels and ITT, leave the hypothalamic-pituitary -adrenal function intact. Finally, these shea-term systemic effects we re not associated with any of the noticeable side-effects usually obse rved during long-term treatment with glucocorticoids.